DJ Arix Bioscience PLC: Clinical development update from portfolio company LogicBio Arix Bioscience PLC (ARIX) Arix Bioscience PLC: Clinical development update from portfolio company LogicBio 02-Feb-2022
/PRNewswire/ LogicBio Therapeutics, Inc. (Nasdaq: LOGC), a clinical-stage genetic medicine company, today provided updates around its SUNRISE Phase 1/2.
LEXINGTON, Mass., Dec. 22, 2021 /PRNewswire/ LogicBio Therapeutics, Inc. , a clinical-stage genetic medicine company, today provided updates around its SUNRISE Phase 1/2 clinical trial. | December 22, 2021